# Evaluation of the Efficacy and Safety of the Dermal Filler for Female Intimate Area Hydration and Atrophy of the Vagina.

> **NCT04659668** · NA · COMPLETED · sponsor: **Mesoestetic Pharma Group S.L.** · enrollment: 37 (actual)

## Conditions studied

- Vaginal Atrophy
- Vulvovaginal Signs and Symptoms
- Dyspareunia
- Urinary Incontinence

## Interventions

- **DEVICE:** MMG-23-04-2019

## Key facts

- **NCT ID:** NCT04659668
- **Lead sponsor:** Mesoestetic Pharma Group S.L.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-11-11
- **Primary completion:** 2020-06-12
- **Final completion:** 2020-08-17
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2020-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04659668

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04659668, "Evaluation of the Efficacy and Safety of the Dermal Filler for Female Intimate Area Hydration and Atrophy of the Vagina.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04659668. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*